These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9564475)

  • 1. Influenza vaccine efficacy in young, healthy adults.
    Grotto I; Mandel Y; Green MS; Varsano N; Gdalevich M; Ashkenazi I; Shemer J
    Clin Infect Dis; 1998 Apr; 26(4):913-7. PubMed ID: 9564475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza vaccine effectiveness in hospitalised Hong Kong children: Feasibility of estimates from routine surveillance data.
    Yeung KHT; Chan KCC; Chan PKS; Lam DSY; Sham PCO; Yau YS; Chan WH; Chiu WK; Ng KL; Ng DKK; Chan IMC; Nelson EAS
    Vaccine; 2018 Jun; 36(24):3477-3485. PubMed ID: 29739719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B.
    Sugaya N; Nerome K; Ishida M; Matsumoto M; Mitamura K; Nirasawa M
    JAMA; 1994 Oct; 272(14):1122-6. PubMed ID: 7933325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010.
    Njuguna H; Ahmed J; Oria PA; Arunga G; Williamson J; Kosgey A; Muthoka P; Mott JA; Breiman RF; Katz MA
    Vaccine; 2013 Sep; 31(41):4662-7. PubMed ID: 23859843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study.
    Heinonen S; Silvennoinen H; Lehtinen P; Vainionpää R; Ziegler T; Heikkinen T
    Lancet Infect Dis; 2011 Jan; 11(1):23-9. PubMed ID: 21106443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical presentations for influenza and influenza-like illness in young, immunized soldiers.
    McNeill KM; Vaughn BL; Brundage MB; Li Y; Poropatich RK; Gaydos JC
    Mil Med; 2005 Jan; 170(1):94-7. PubMed ID: 15724862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial.
    Beran J; Vesikari T; Wertzova V; Karvonen A; Honegr K; Lindblad N; Van Belle P; Peeters M; Innis BL; Devaster JM
    J Infect Dis; 2009 Dec; 200(12):1861-9. PubMed ID: 19909082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of inactivated trivalent influenza vaccine in alleviating the febrile illness of culture-confirmed influenza in children in the 2000-2001 influenza season.
    Kamada M; Nagai T; Kumagai T; Igarashi M; Ihara T; Okafuji T; Ochiai H; Sakiyama H; Shimomura K; Suzuki E; Torigoe S; Miyazaki C; Miyata A; Yuri K; Ito Y; Nakayama T; Kase T; Okuno Y
    Vaccine; 2006 Apr; 24(17):3618-23. PubMed ID: 16530300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which influenza vaccine formulation should be used in Kenya? A comparison of influenza isolates from Kenya to vaccine strains, 2007-2013.
    Waiboci LW; Mott JA; Kikwai G; Arunga G; Xu X; Mayieka L; Emukule GO; Muthoka P; Njenga MK; Fields BS; Katz MA
    Vaccine; 2016 May; 34(23):2593-601. PubMed ID: 27079931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of 3 seasonal trivalent influenza vaccines in the Chinese military.
    Gao D; Yang H; Deng B; Yin G; Song W; Zhang H; Li Y
    Hum Vaccin Immunother; 2016 Oct; 12(10):2634-2639. PubMed ID: 27348250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for febrile respiratory illness and mono-viral infections in a semi-closed military environment: a case-control study.
    Pang J; Jin J; Loh JP; Tan BH; Koh WH; Ng SH; Ho ZJ; Gao Q; Cook AR; Hsu LY; Lee VJ; Chen MI
    BMC Infect Dis; 2015 Jul; 15():288. PubMed ID: 26208494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of inactivated and live attenuated influenza vaccines.
    Monto AS; Ohmit SE; Petrie JG; Johnson E; Truscon R; Teich E; Rotthoff J; Boulton M; Victor JC
    N Engl J Med; 2009 Sep; 361(13):1260-7. PubMed ID: 19776407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol.
    Hirsch A; Katz MA; Laufer Peretz A; Greenberg D; Wendlandt R; Shemer Avni Y; Newes-Adeyi G; Gofer I; Leventer-Roberts M; Davidovitch N; Rosenthal A; Gur-Arie R; Hertz T; Glatman-Freedman A; Monto AS; Azziz-Baumgartner E; Ferdinands JM; Martin ET; Malosh RE; Neyra Quijandría JM; Levine M; Campbell W; Balicer R; Thompson MG;
    BMC Infect Dis; 2018 Nov; 18(1):550. PubMed ID: 30400834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological Characteristics of the 2014/2015 Influenza Season Based on Molecular Analysis of Biological Material Derived from I-MOVE Study.
    Hallmann-Szelińska E; Bednarska K; Korczyńska M; Paradowska-Stankiewicz I; Brydak LB
    Adv Exp Med Biol; 2016; 921():81-5. PubMed ID: 27131497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influenza season 1999/2000 and vaccine composition for the season 2000/01].
    Rimmelzwaan GF; de Jong JC; Bartelds AI; Dorigo-Zetsma JW; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2000 Oct; 144(41):1968-71. PubMed ID: 11048562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using surveillance to evaluate influenza vaccine effectiveness.
    Jackson LA
    J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccine for prevention of mild and moderate-to-severe influenza in children.
    Jain VK; Rivera L; Zaman K; Espos RA; Sirivichayakul C; Quiambao BP; Rivera-Medina DM; Kerdpanich P; Ceyhan M; Dinleyici EC; Cravioto A; Yunus M; Chanthavanich P; Limkittikul K; Kurugol Z; Alhan E; Caplanusi A; Durviaux S; Boutet P; Ofori-Anyinam O; Chandrasekaran V; Dbaibo G; Innis BL
    N Engl J Med; 2013 Dec; 369(26):2481-91. PubMed ID: 24328444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prophylactic efficacy of the trivalent polymer-subunit influenza vaccine Grippol (3)].
    El'shina GA; Gorbunov MA; Shervarli VI; Lonskaia NI; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG; Pavlova LI; Malinovskiĭ AA
    Voen Med Zh; 1997 Feb; 318(2):47-9. PubMed ID: 9148581
    [No Abstract]   [Full Text] [Related]  

  • 20. The evolving history of influenza viruses and influenza vaccines.
    Hannoun C
    Expert Rev Vaccines; 2013 Sep; 12(9):1085-94. PubMed ID: 24024871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.